Related Experiment Video
Updated: Apr 20, 2026

An Air-liquid Interface Bronchial Epithelial Model for Realistic, Repeated Inhalation Exposure to Airborne Particles for Toxicity Testing
Published on: May 13, 2020
Frequency of contamination of single-patient-use nebulizers over time
David J Weber1, Maria F Gergen, Emily E Sickbert-Bennett
1Department of Hospital Epidemiology, University of North Carolina (UNC) Health Care, Chapel Hill, North Carolina.
Abstract:
Adult hospitalized patients with cystic fibrosis commonly receive nebulized medications. For single-patient-use nebulizers that are cleaned after each use, there is infrequent nebulizer contamination (0%-11%) with only low numbers of epidemiologically important pathogens (less than 100 colony-forming units), and this contamination is similar after 24, 48, and 72 hours of use.
Insights
For hospitalized cystic fibrosis patients, single-patient nebulizers cleaned after each use show infrequent contamination. Pathogen levels remain low (<100 CFU) regardless of 24, 48, or 72 hours of use.
Area of Science:
- Medical Microbiology
- Pulmonology
- Infectious Disease
Background:
- Hospitalized adult patients with cystic fibrosis frequently use nebulized medications.
- Proper cleaning of nebulizer equipment is crucial for infection control in immunocompromised patients.
Purpose of the Study:
- To assess the contamination levels of single-patient-use nebulizers in hospitalized cystic fibrosis patients.
- To determine if the duration of nebulizer use (24, 48, 72 hours) impacts bacterial contamination after cleaning.
Main Methods:
- Single-patient-use nebulizers were used by hospitalized cystic fibrosis patients.
- Nebulizers were cleaned after each use.
- Nebulizer components were sampled and cultured at 24, 48, and 72 hours of use.
- Cultures were assessed for the presence and quantity of epidemiologically important pathogens.
Main Results:
- Nebulizer contamination was infrequent, occurring in 0%-11% of samples.
- When contamination was present, pathogen levels were consistently low, below 100 colony-forming units (CFU).
- Contamination rates and pathogen loads were similar across 24, 48, and 72 hours of nebulizer use.
Conclusions:
- Single-patient-use nebulizers, when cleaned appropriately after each use, demonstrate a low risk of significant bacterial contamination in hospitalized cystic fibrosis patients.
- The duration of use up to 72 hours does not appear to increase the risk of clinically relevant nebulizer contamination.
- These findings support the safety of current cleaning protocols for nebulizers in this patient population.
More Related Videos
09:02An Experimental Model to Study Tuberculosis-Malaria Coinfection upon Natural Transmission of Mycobacterium tuberculosis and Plasmodium berghei
Published on: February 17, 2014
05:07Development of a Nose-only Inhalation Toxicity Test Chamber That Provides Four Exposure Concentrations of Nano-sized Particles
Published on: March 18, 2019
Related Concept Videos
Oxygen Delivering System II: Venturi Mask and Transtracheal Oxygen
Venturi Mask
The Venturi mask, named after the Venturi effect, is designed to deliver precise oxygen concentrations. It consists of a large tube with an oxygen inlet that narrows down, causing a pressure drop that pulls air in through adjustable side ports. The mask is a lightweight,...
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Inhaled Medications
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...